AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Texas

HB4423

Relating to the establishment of the Psilocybin Research Advisory Council.

Status

Did not pass; died when the session ended

2023 Session

IntroducedMar 9, 2023 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Josey Garcia (Bipartisan)
Type: Study/Task Force
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Relating to the establishment of the Psilocybin Research Advisory Council.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: capitol.texas.gov

Legislative history

March 21, 2023
Referred
March 21, 2023
Referred
March 9, 2023
Introduced

Loading bill…